Continuous Glucose Monitoring in Children with Type 1 Diabetes Improves Well-Being, Alleviates Worry and Fear of Hypoglycemia

Diabetes Technology & Therapeutics
Sze May NgAstha Soni

Abstract

There is limited published evidence regarding the psychological effect of use of continuous glucose monitoring (CGM) in the pediatric population with type 1 diabetes mellitus on metabolic control, fear of hypoglycemia, and patient or carer well-being. The aim of this study was to evaluate the effects of CGM on patient and carer well-being, worry, fear of hypoglycemia, and glycemic control. Children aged >12 years independently completed the hypoglycemia fear survey (HFS). Parents and carers of children using CGM for a minimum of 12 months were asked to complete a modified version of the hypoglycemia fear survey for parents of young children (HFS-P) before and after CGM usage. Sixteen patients (8 boys) were included with median age of 13.5 years (2-17 years) and use of CGM for a minimum of 12 months. There was no significant improvement in the glycated hemoglobin after 12 months of CGM usage. Parents of all 16 patients completed the HFS-P survey. Of 12 young people eligible (age >12 years), 11 returned the HFS survey. Significant improvement was seen in both parental and patient fear of hypoglycemia after CGM (P < 0.001 and P = 0.003, respectively). The use of CGM did not show any significant improvement in glycemic control afte...Continue Reading

References

Apr 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·S PrammingC Binder
Sep 1, 1987·Diabetes Care·D J CoxJ Butterfield
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jun 27, 1998·Journal of Pediatric Endocrinology & Metabolism : JPEM·W L ClarkeD J Cox
May 6, 2004·The Journal of Pediatrics·Michael J HallerJanet H Silverstein
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Michael Brownlee, Irl B Hirsch
Aug 26, 2006·Nature Clinical Practice. Neurology·Elisabeth A NorthamFergus J Cameron
Jun 19, 2008·The Medical Journal of Australia·Emily TuChristopher Semsarian
Sep 10, 2008·The New England Journal of Medicine·William V TamborlaneDongyuan Xing
Dec 24, 2008·Journal of Clinical Psychology in Medical Settings·Susana R PattonScott W Powers
Aug 14, 2009·Diabetes Care·UNKNOWN Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study GroupWilliam V Tamborlane
Feb 16, 2010·Diabetes Technology & Therapeutics·Jean Halford, Claudia Harris
Sep 24, 2011·Diabetes Research and Clinical Practice·Joyce P Yi-FrazierUNKNOWN SEARCH for Diabetes in Youth Study Group
Dec 20, 2011·Diabetes Management·Linda Gonder-FrederickWilliam Clarke
Apr 25, 2012·Diabetes Technology & Therapeutics·Jessica T MarkowitzLori M B Laffel
Jun 29, 2014·Journal of Diabetes and Its Complications·Albert Hsieh, Stephen M Twigg
Dec 22, 2014·Acta Diabetologica·Therese AnderbroUnn-Britt Johansson
Feb 11, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·J P NewG Freckmann
Mar 15, 2015·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Ayman A Al HayekFahad S Al Sabaan
Feb 26, 2016·Journal of Diabetes Science and Technology·Martin de BockElizabeth Davis
Jan 25, 2017·Diabetes Technology & Therapeutics·Susana R PattonScott W Powers
Jul 13, 2018·Families, Systems & Health : the Journal of Collaborative Family Healthcare·Anthony T VescoJill Weissberg-Benchell

❮ Previous
Next ❯

Software Mentioned

Statistical Package for the Social Sciences
HFS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.